Stay updated on Sitravatinib Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Advanced NSCLC Clinical Trial page
- Check7 days agoChange DetectedA revision entry updated from v3.4.0 to v3.4.1, with no substantive content changes indicated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.4 is shown; no observable updates to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe Locations section now includes Connecticut as a site. The HHS Vulnerability Disclosure and Connecticut Locations entry were removed, and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check85 days agoChange DetectedThe government funding status notice on the page was removed, eliminating the related warning about updates and operation status.SummaryDifference0.4%

Stay in the know with updates to Sitravatinib Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.